Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells–a type of cancer immunotherapy–that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
